Axillary Lymph Node Size Chart: What’s Normal?

Normal axillary lymph nodes typically have a thin outer rim of tissue, called the cortex, measuring less than 3 mm, along with a visible bright center known as the fatty hilum. On ultrasound, those two features matter far more than the overall length or width of the node, which is why a single “size chart” can be misleading. A node that looks large on imaging can be perfectly healthy, while a smaller node with a thickened cortex can harbor disease. Understanding what radiologists actually measure, and why, helps make sense of any report that mentions your axillary lymph nodes.

What Radiologists Actually Measure

When you see an imaging report describing axillary lymph nodes, the numbers that matter most are cortical thickness and the presence of a fatty hilum, not the node’s overall dimensions. A healthy node looks something like a kidney bean: a thin dark outer rim (the cortex) surrounding a bright fatty center (the hilum). Radiologists classify a node as likely benign when the cortex is even and under 3 mm thick, and the hilum is clearly visible. When the cortex thickens beyond 3 mm, or when the hilum starts to disappear, concern rises.

One widely used classification system categorizes nodes as benign (even cortex under 3 mm), indeterminate (even cortex at or above 3 mm, or under 3 mm but unevenly thickened), and suspicious (focally thickened cortex at or above 3 mm, or an absent fatty hilum).¹ That three-tier approach gives clinicians a practical framework, but the thresholds are not absolute cutoffs. A cortex measuring 3.1 mm in a patient with no other risk factors is treated very differently from a 3.1 mm cortex in someone with a known breast tumor.

When cortical thickness climbs above 5 mm and the normal hilum is effaced, the association with malignancy becomes much stronger.² A study of newly diagnosed breast cancer patients found that nodes with metastatic disease had measurably thicker cortices than negative nodes, and that an abnormal hilum roughly tripled the odds of metastasis while diffuse cortical thickening nearly tripled them as well.³ So the real takeaway is this: cortical thickness and hilum appearance are the workhorses of lymph node assessment, and overall node size by itself tells you relatively little.

Why Overall Node Size Can Be Misleading

People searching for a “size chart” often expect a simple number: anything under, say, 1 cm is fine, and anything over is worrying. That logic works reasonably well for some lymph node groups in the body, but axillary nodes are trickier. They are among the largest normal lymph nodes you have, and their total dimensions vary dramatically from person to person based on body composition, age, and immune activity.

Body mass index is a major driver of overall node size. Research using mammography measurements found a strong association between higher BMI and larger axillary nodes, with nodes growing roughly 0.6 mm longer and 0.3 mm wider for every one-unit increase in BMI. Crucially, the cortex width did not change with increasing BMI. The size increase was driven entirely by expansion of the fatty hilum, meaning the node looked bigger on imaging but was structurally normal.⁴ A separate study confirmed the same pattern: all lymph node measurements and the hilum-to-cortex ratio increased with BMI, but cortex width stayed the same.⁵

This is one of the main reasons a blanket size chart would fail you. A 2 cm axillary node in a person with a high BMI may just be full of fat and entirely healthy, while a 1 cm node in a lean person with a thickened cortex and no visible hilum could be harboring metastatic disease. Any imaging report that simply calls a node “enlarged” without describing the cortex and hilum is giving you incomplete information.

What a Suspicious Node Looks Like on Imaging

Radiologists look at several features beyond cortical thickness when deciding whether a node needs a closer look. In breast cancer staging, the combination of ultrasound features gives a more complete picture than any single measurement. Using a cortical thickness cutoff of 3 mm alone yields sensitivity around 83% and specificity around 77% for detecting metastatic involvement.⁶ That is decent but not perfect, which is why other features get layered in.

Findings that raise suspicion include:

Absent fatty hilum: the bright center of the node is no longer visible, suggesting the normal architecture has been replaced.
Round shape: healthy nodes tend to be oval or kidney-bean shaped; rounding suggests internal expansion.
Focal cortical thickening: a localized bulge in the cortex rather than uniform thickening, sometimes indicating a small deposit of tumor.
Abnormal blood flow: increased blood supply at the periphery of the node instead of through the hilum.

Research in high-risk breast cancer patients showed that cortical abnormalities tended to correlate with earlier-stage nodal disease, while features like loss of the hilum and abnormal shape predicted more extensive involvement.⁷ On MRI, perifocal edema (fluid in the fat surrounding the node, visible as a bright signal) has been reported to have the highest positive predictive value for malignancy among the features studied.⁸

When Enlarged Nodes Are Not Cancer

The majority of enlarged axillary lymph nodes turn out to be caused by something other than malignancy. Infections, immune reactions, and inflammatory conditions are all common culprits, and knowing about them can help you avoid unnecessary panic if your report flags an abnormal-looking node.

One classic cause is cat scratch disease. A scratch deep enough to break the skin can introduce the bacterium Bartonella henselae, leading to tender, swollen lymph nodes that drain the affected area. When the scratch is on the hand or arm, the axillary nodes are the ones that swell. Cat scratch lymphadenitis can produce nodes large enough to mimic lymphoma on imaging, which sometimes leads to biopsy.⁹ In a large study analyzing lymph node biopsies from nearly 800 patients with suspected cat scratch disease, the most commonly identified organism was Bartonella henselae, found in about a third of cases.¹⁰

Autoimmune diseases are another cause. In patients with rheumatoid arthritis, enlarged lymph nodes tend to cluster in the axillary region specifically, whereas in systemic lupus erythematosus, lymphadenopathy is usually more generalized and the nodes are smaller.¹¹ For someone with a known autoimmune condition who notices a swollen node under the arm, the most likely explanation is disease activity, not a new malignancy, though the distinction still needs to be made clinically.

Vaccine-Related Lymph Node Swelling

COVID-19 vaccination brought axillary lymphadenopathy to public awareness in a way few other causes ever had. A systematic review found that clinically detectable lymphadenopathy occurred in about 0.4% of vaccinated individuals, with the swollen nodes averaging around 18 mm and appearing within about a week of vaccination.¹² That 0.4% figure represents the rate that was clinically detected, meaning palpable or incidentally found on imaging. The actual rate of some degree of immune-related swelling in the draining axillary nodes was almost certainly higher.

What surprised many radiologists was how long the swelling could persist. A prospective study tracking women with vaccine-related axillary lymphadenopathy on ultrasound found that only about a quarter had complete resolution at six weeks. Among those followed to about 12 weeks, roughly half still showed persistent lymphadenopathy, although cortical thickness was gradually decreasing over time.¹³ After a booster dose, lymphadenopathy resolved at a mean of about 102 days, which was actually faster than the resolution seen after the initial dose series.¹⁴

This became a practical problem in breast imaging. A woman getting a screening mammogram shortly after vaccination might show enlarged ipsilateral axillary nodes, prompting unnecessary callbacks and anxiety. Radiology organizations developed specific guidance to reduce that confusion, recommending that screening be scheduled before vaccination or at least four to six weeks after, and that known vaccine-related findings be noted rather than worked up aggressively.¹⁵ Though the pandemic is no longer at its peak, this guidance still applies to any vaccination in the arm, as seasonal flu shots and other injections can produce the same effect on a smaller scale.

Silicone Implants and Axillary Node Enlargement

If you have silicone breast implants, an enlarged axillary node has one additional possible explanation that many people do not consider. When a silicone implant ruptures, tiny droplets of silicone can migrate to nearby lymph nodes, triggering an inflammatory reaction that forms granulomas and causes the nodes to enlarge. This is called silicone lymphadenopathy.¹⁶

A retrospective study of 52 patients with silicone lymphadenopathy found that implant rupture was present in nearly 89% of cases, and the axillary nodes were the most commonly involved group, affected in about 87% of patients. Interestingly, the majority of patients (about 69%) were asymptomatic; the node enlargement was discovered incidentally on imaging.¹⁷ The concern, of course, is distinguishing this benign swelling from cancer recurrence, particularly in patients who had implants placed after mastectomy for breast cancer. In one reported case, a woman presented with progressive axillary lymph node enlargement 12 years after implant reconstruction for breast cancer, but biopsy revealed silicone deposits with no evidence of malignancy.¹⁸ Silicone can sometimes be recognized on MRI or ultrasound by its characteristic appearance, but biopsy is often needed to be certain.

How Physical Exam Compares to Imaging

Many people discover a swollen lymph node by feel rather than on a scan, and a natural question is how reliable that finding is. The honest answer is: not very, at least for ruling disease in or out. In a large multicenter trial evaluating axillary staging after chemotherapy for breast cancer, palpation alone had a sensitivity of only about 8%, meaning it detected abnormal nodes in fewer than one in ten cases where cancer was actually present. Specificity was high at about 95%, meaning a palpable finding was usually correct when it was positive, but the overwhelmingly common result was a false negative: nodes that felt normal but harbored cancer.¹⁹

Ultrasound did better with a sensitivity of about 24%, but that is still missing three out of four positive cases. Among patients whose axillae were clinically classified as node-negative based on both palpation and ultrasound, half actually had no disease, a quarter had one to two involved nodes, and another quarter had more than two.¹⁹ These numbers come from a specific setting (post-chemotherapy restaging), so they represent a harder scenario than first-time assessment. But they illustrate why imaging alone is often not enough and why suspicious nodes get biopsied rather than just watched.

What Happens When a Biopsy Is Recommended

If your radiologist flags an axillary node as suspicious, the next step is usually a needle biopsy under ultrasound guidance. Two main approaches exist: fine-needle aspiration and core needle biopsy. Fine-needle aspiration uses a thin needle to suction out cells, while core needle biopsy uses a slightly larger needle to extract a small cylinder of tissue.

A meta-analysis comparing the two methods found that core needle biopsy had higher sensitivity, correctly identifying about 88% of metastatic nodes versus about 74% for fine-needle aspiration. Both had essentially perfect specificity, meaning a positive result was reliable either way.²⁰ The tradeoff is that core needle biopsy had a higher complication rate (about 7% versus 1% for fine-needle aspiration), though most complications were minor, such as bruising or temporary discomfort. Fine-needle aspiration, meanwhile, was more likely to require a repeat procedure (about 4% of the time versus under 1% for core biopsy), often because the sample was too small for a definitive diagnosis.

In practice, many centers now default to core needle biopsy for suspicious axillary nodes because the higher tissue yield reduces the need for follow-up procedures, but fine-needle aspiration remains useful in certain situations, such as when the node is very small or in a location that makes a larger needle riskier.

Incidental Findings on Routine Breast Ultrasound

If you’ve had a diagnostic breast ultrasound and the report mentions an axillary finding, it is worth knowing how common that is and what it typically means. A review of nearly 20,000 diagnostic breast ultrasounds found that incidental axillary findings rated as indeterminate or suspicious occurred in only about 0.5% of exams. None of those incidental findings led to a diagnosis of an occult breast cancer.²¹ That does not mean axillary screening is pointless, but it does suggest that if you have no known breast pathology and an incidental axillary node is flagged on routine imaging, the probability that it represents something dangerous is low.

This is also relevant to the broader question of how much anxiety an imaging report should generate. Radiologists increasingly appreciate that labeling a node “abnormal” or “enlarged” without clear context causes unnecessary worry. Specific language about cortical thickness, hilum appearance, and clinical context gives both the referring physician and the patient a much better sense of what is going on than a vague size measurement ever could.

Lymphoma and Other Non-Breast Causes

Not all axillary lymph node abnormalities relate to breast disease. Lymphoma, both Hodgkin and non-Hodgkin types, can present with enlarged axillary nodes. On CT, lymphoma nodes typically appear uniformly enlarged with homogeneous enhancement and without the internal breakdown or necrosis that is more common in metastatic disease. However, some lymphoma subtypes show atypical imaging features, and several other conditions can mimic lymphoma, including certain viral infections in immunocompromised patients and metastatic cancers from other primary sites.²² In these cases, the imaging appearance alone is rarely enough for a definitive diagnosis, and tissue sampling becomes essential.

Melanoma from the arm, hand, or trunk can also metastasize to axillary nodes, as can other skin cancers. Infections in the arm, hand, or chest wall (anything from a wound infection to cellulitis) will predictably cause reactive swelling in the axillary nodes that drain those regions. In children, axillary lymphadenopathy is overwhelmingly related to infection, and care is taken to rule out malignancy primarily through clinical history and observation rather than rushing to biopsy.²³

How Fat-Enlarged Nodes Complicate Screening in Obese Patients

The relationship between body weight and axillary node size creates a specific diagnostic challenge. As described earlier, higher BMI makes nodes appear larger on imaging due to fat infiltration of the hilum, without changing cortical thickness. This means that in most cases, a radiologist can still distinguish a fat-enlarged benign node from a truly suspicious one by focusing on the cortex. But there is a wrinkle: research has found that fat-enlarged axillary lymph nodes in obese patients are associated with node-positive breast cancer.²⁴

The reason for this association is not fully understood. It may reflect the broader metabolic and inflammatory environment associated with obesity, or it may be that fat-infiltrated nodes are subtly altered in ways that facilitate tumor spread. Whatever the mechanism, it means that obese patients with breast cancer deserve careful axillary assessment, and that a blanket reassurance of “it’s just fat” when a node appears large may not always be appropriate. The cortex and hilum still need to be scrutinized with the same rigor applied to any other patient, and possibly more.